Structure-activity relationships of novel anti-malarial agents.: Part 7:: N-(3-benzoyl-4-tolylacetylaminophenyl)-3-(5-aryl-2-uryl)acrylic acid amides with polar moieties

被引：21

作者：

Wiesner, J

Mitsch, A

Jomaa, H

Schlitzer, M

机构：

[1] Univ Munich, Zentrum Pharmaforsch, Dept Pharm, D-81377 Munich, Germany

[2] Univ Marburg, Inst Pharmazeut Chem, D-35032 Marburg, Germany

[3] Univ Giessen, Inst Biochem, D-35249 Giessen, Germany

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2003年 / 13卷 / 13期

关键词：

D O I：

10.1016/S0960-894X(03)00353-6

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

In a previous report, we have provided evidence that novel anti-malarial compounds based on 2,5-diaminobenzophenone farnesyltransferase inhibitors might benefit from the presence of a polar moiety at the para position of the terminal phenyl of the arylfurylacryloyl partial structure. Here, we demonstrate that different moieties with hydrogen bond acceptor properties lead to equipotent or even improved anti-malarial activity in comparison to the nitro group described before. (C) 2003 Elsevier Science Ltd. All rights reserved.

引用

收藏

页码：2159 / 2161

页数：3

相关论文

共 14 条

[1] Antimalarial activity of 77 phospholipid polar head analogs:: Close correlation between inhibition of phospholipid metabolism and in vitro Plasmodium falciparum growth [J].

Ancelin, ML ;

Calas, M ;

Bompart, J ;

Cordina, G ;

Martin, D ;

Ben Bari, M ;

Jei, T ;

Druilhe, P ;

Vial, HJ .

BLOOD, 1998, 91 (04) :1426-1437

[2] Exploration of novel aryl binding sites of farnesyltransferase using molecular modeling and benzophenone-based farnesyltransferase inhibitors [J].

Böhm, M ;

Mitsch, A ;

Wissner, P ;

Sattler, I ;

Schlitzer, M .

JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (19) :3117-3124

[3] QUANTITATIVE ASSESSMENT OF ANTI-MALARIAL ACTIVITY INVITRO BY A SEMIAUTOMATED MICRODILUTION TECHNIQUE [J].

DESJARDINS, RE ;

CANFIELD, CJ ;

HAYNES, JD ;

CHULAY, JD .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1979, 16 (06) :710-718

[4] Medical need, scientific opportunity and the drive for antimalarial drugs [J].

Ridley, RG .

NATURE, 2002, 415 (6872) :686-693

[5] The economic and social burden of malaria [J].

Sachs, J ;

Malaney, P .

NATURE, 2002, 415 (6872) :680-685

[6] Synthesis, molecular modeling, and structure-activity relationship of benzophenone-based CAAX-peptidomimetic farnesyltransferase inhibitors [J].

Sakowski, J ;

Böhm, M ;

Sattler, I ;

Dahse, HM ;

Schlitzer, M .

JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (18) :2886-2899

[7] Structure based design of benzophenone-based non-thiol farnesyltransferase inhibitors [J].

Schlitzer, M .

CURRENT PHARMACEUTICAL DESIGN, 2002, 8 (19) :1713-1722

[8] 2,2-dimethyl-4,5-diaryl-3(2H) furanone derivatives as selective cyclo-oxygenase-2 inhibitors [J].

Shin, SS ;

Noh, MS ;

Byun, YJ ;

Choi, JK ;

Kim, JY ;

Lim, KM ;

Ha, JY ;

Kim, JK ;

Lee, CH ;

Chung, S .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (02) :165-168

[9]

TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840

[10] Structure-activity relationships of novel anti-malarial agents:: Part 5.: N-(4-acylamino-3-benzoylphenyl)-[5-(4-nitrophenyl)-2-furyl]acrylic acid amides [J].

Wiesner, J ;

Kettler, K ;

Sakowski, J ;

Ortmann, R ;

Jomaa, H ;

Schlitzer, M .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (03) :361-363